| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 02/27/1996 | US5494673 Phosphazene polyelectrolytes as immunoadjuvants |
| 02/27/1996 | US5494665 Metal chloride, lysozyme chloride, isotonic agent, nonionic thickening agent and preservative |
| 02/27/1996 | CA2170505A1 Compositions and methods for the administration of .delta.-aminolevulinic acid and pharmaceutical equivalents thereof |
| 02/27/1996 | CA2030204C Pharmaceutical compositions of tebufelone |
| 02/24/1996 | CA2156768A1 Pharmaceutical formulations, their preparation and use |
| 02/22/1996 | WO1996005544A1 Current-to-pressure transducer with selectable, adjustable input filter |
| 02/22/1996 | WO1996005321A1 Gene therapy for restenosis using an adenoviral vector |
| 02/22/1996 | WO1996005320A1 Adenovirus comprising a gene coding for glutathion peroxidase |
| 02/22/1996 | WO1996005297A1 Method of gene therapy using dna vectors without selection marker gene |
| 02/22/1996 | WO1996005218A1 Delivery of nucleic acids |
| 02/22/1996 | WO1996004953A1 Orally administrable delivery device |
| 02/22/1996 | WO1996004931A1 Peroral immunogen composition and process for producing the same |
| 02/22/1996 | WO1996004918A1 Prednisolone metasulphobenzoate preparation for the treatment of inflammatory bowel disease |
| 02/22/1996 | WO1996004917A1 Remedy for myotonic dystrophy |
| 02/22/1996 | WO1996004916A1 Methods and compositions useful in prophylaxis and therapy of endotoxin related conditions |
| 02/22/1996 | WO1996004908A1 Pharmaceutical formulation containing amoxycillin and potassium clavulanate |
| 02/22/1996 | WO1996004907A1 Pharmaceutical formulation |
| 02/22/1996 | WO1996004904A1 Pharmaceutically stable oxaliplatinum preparation |
| 02/22/1996 | WO1996004894A1 Anti-acne cosmetic compositions |
| 02/22/1996 | WO1996004893A1 Composition for the selective release of an active ingredient |
| 02/22/1996 | WO1996004892A1 Novel cimetidine-containing compositions and combinations derived therefrom |
| 02/22/1996 | WO1996004891A1 Formulation and use of carotenoids in treatment of cancer |
| 02/22/1996 | WO1996004890A1 Vesicle formulation |
| 02/22/1996 | WO1996004889A1 Process for preparing beclomethasone dipropionate freon® clathrate |
| 02/22/1996 | WO1996004888A1 Oral compositions of h2-antagonists |
| 02/22/1996 | WO1996004787A1 Combined virustatic antimediator (covam) treatment of common colds |
| 02/22/1996 | DE4430593A1 Liposomal verkapseltes Taxol, seine Herstellung und seine Verwendung Liposomally encapsulated Taxol, its preparation and its use |
| 02/22/1996 | DE4430592A1 Liposomale Zubereitung, ihre Herstellung und ihre Verwendung Liposomal preparation, their preparation and their use |
| 02/22/1996 | DE4429667A1 Estradiol-TTS mit wasserbindenden Zusätzen Estradiol-TTS with water-binding additives |
| 02/22/1996 | DE4429664A1 Estradiol-TTS mit wasserbindenden Zusätzen Estradiol-TTS with water-binding additives |
| 02/22/1996 | DE4429663A1 Transdermal therapeutic system for hydrolysable medicaments |
| 02/22/1996 | DE4428986A1 New alprazolam formulation with improved release kinetics |
| 02/22/1996 | DE19530509A1 Prepn. of solid, stomach-acid resistant pharmaceutical prepns. |
| 02/22/1996 | CA2197234A1 Composition for the selective release of an active ingredient |
| 02/22/1996 | CA2197195A1 Current-to-pressure transducer with selectable, adjustable input filter |
| 02/22/1996 | CA2197170A1 Orally administrable delivery device |
| 02/22/1996 | CA2196982A1 Anti-acne cosmetic compositions |
| 02/22/1996 | CA2196415A1 Peroral immunogen composition and process for producing the same |
| 02/22/1996 | CA2196203A1 Combined virustatic antimediator (covam) treatment of common colds |
| 02/22/1996 | CA2196171A1 Process for preparing beclomethasone dipropionate freon? clathrate |
| 02/22/1996 | CA2174232A1 Gene therapy for restenosis using an adenoviral vector |
| 02/21/1996 | EP0697397A1 L-carnitine salt and compositions containing same |
| 02/21/1996 | EP0697214A1 Liposomal cyclosporin pharmaceutical formulations |
| 02/21/1996 | EP0697002A1 Seal configuration for aerosol canister |
| 02/21/1996 | EP0696921A1 Veterinary composition containing a proton pump inhibitor |
| 02/21/1996 | EP0696920A1 Improved pharmaceutical acceptable compositions containing an alcohol and a hydrophobic drug |
| 02/21/1996 | EP0696918A1 Composition containing cholestyramine and method of producing the same |
| 02/21/1996 | EP0696917A1 Method and means for inhibiting posterior capsule opacification |
| 02/21/1996 | CN1117266A Stable protein: phospholipid compositions and methods |
| 02/21/1996 | CN1117048A A process for preparing an intermediate compound of the benzothiazole compounds |
| 02/21/1996 | CN1116953A Hematoma liquefier |
| 02/21/1996 | CN1116946A Medicine for abstaining from drugs and its preparation |
| 02/21/1996 | CN1116945A Capsule for gastric diseases |
| 02/21/1996 | CN1116940A Medicinal composite for rheumatism |
| 02/21/1996 | CN1116935A Analgesic plaster |
| 02/21/1996 | CN1116934A Asthma relieving cough plaster |
| 02/21/1996 | CN1116933A Preparation for zhonghua garlic oil pill |
| 02/21/1996 | CN1116930A 1,6-diphosphofructose sodium salt capsule |
| 02/21/1996 | CN1116926A Pharmaceutical preparation controlled to release medicinal active ingredient at targeted site in intestinal tract |
| 02/21/1996 | CN1116925A Cod liver oil emulsion and its preparation |
| 02/21/1996 | CN1116919A Anti-prospermia condom |
| 02/21/1996 | CN1116903A Lipid vesicles and aqueous emulsions containing thom, and to a process for producing them |
| 02/21/1996 | CN1031038C Prolonged release of biologically active polyepeptides |
| 02/21/1996 | CN1031036C Multi-layer granule |
| 02/20/1996 | US5493051 Lifibrol and its use |
| 02/20/1996 | US5493019 Useful as antiinflammatory and antiproliferative agents |
| 02/20/1996 | US5492938 Pharmaceutical composition and dietary supplement containing docosarexaenoic acid obtained from dinoflagellates |
| 02/20/1996 | US5492937 Gel-forming liquid carrier composition |
| 02/20/1996 | US5492936 Bimodal molecular weight hyaluronate formulations and methods for using same |
| 02/20/1996 | US5492701 Atomizing oil in water emulsion containing vitamin a acetate or vitamin e, allowing the spherules formed to fall through countercurrent cold air flow(in tower) into liquid crosslinking agent, then recovering hardened spherules |
| 02/20/1996 | US5492700 Cellulose esters, polyacrylic acids or esters as release-control agents |
| 02/20/1996 | US5492698 Lanoline derivatives as penetration enhancing substances |
| 02/20/1996 | US5492696 Controlled release microstructures |
| 02/20/1996 | US5492692 Blend of nonoxynol oligomers, polyvinylpyrrolidone and iodine |
| 02/20/1996 | US5492689 Administering simultaneously an antiviral agent and two antiinflammatory compounds; synergistic result in treatment of cold or influenza |
| 02/20/1996 | US5492688 Aerosol mixture having 1,1,1,2-tetrafluoroethane as sole propellant, with polar surfactant and micronized drug particles |
| 02/20/1996 | US5492112 Dry powder inhaler |
| 02/20/1996 | CA2155134A1 Branched polysaccharide, microorganism producing it and compositions containing them |
| 02/20/1996 | CA2002298C Storage-stable transdermal patch |
| 02/20/1996 | CA1338079C Adhesion protein micelles |
| 02/20/1996 | CA1338074C Low-viscosity pressure-adherent silicone elastomer compositions |
| 02/15/1996 | WO1996004243A1 Stable vitamin a |
| 02/15/1996 | WO1996004128A1 Method or producing coated tablets |
| 02/15/1996 | WO1996004017A1 Iron-containing nanoparticles with double coating and their use in diagnosis and therapy |
| 02/15/1996 | WO1996004015A1 Microparticle preparations for clearing blood-dissolved substances |
| 02/15/1996 | WO1996004014A1 Controlled-release drug preparation |
| 02/15/1996 | WO1996003991A1 Compositions containing prostaglandin e1 and/or troxerutine complexed with phosphatidylcholine for topical treatment of erectile impotence |
| 02/15/1996 | WO1996003988A1 Process and products for reducing biological fluid levels of a lipid soluble waste |
| 02/15/1996 | WO1996003984A1 Controlled local delivery of chemotherapeutic agents for treating solid tumors |
| 02/15/1996 | WO1996003980A1 Improved effervescent delivery system |
| 02/15/1996 | WO1996003979A1 Apparatus and method for preparing solid forms with controlled release of the active ingredient |
| 02/15/1996 | WO1996003978A1 Solid delivery systems for controlled release of molecules incorporated therein and methods of making same |
| 02/15/1996 | WO1996003977A1 A liposomal delivery system for biologically active agents |
| 02/15/1996 | WO1996003976A1 Tastemasked liquid pharmaceutical delivery system |
| 02/15/1996 | WO1996003975A1 Improved bioadhesive pharmaceutical delivery system |
| 02/15/1996 | WO1996003973A1 Highly bioadhesive and mucoadhesive compositions for the treatmenof epithelia and mucous membranes |
| 02/15/1996 | WO1996003972A1 Deposition of materials to surfaces using zwitterionic carrier particles |
| 02/15/1996 | WO1996003965A1 Method for treating non-ocular epithelial disorders |
| 02/15/1996 | WO1996003871A1 Gel formulation |
| 02/15/1996 | WO1995028124A3 An adjunctive polymer system for use with medical device |